Last reviewed · How we verify
Ross River Virus (RRV) Vaccine
The Ross River Virus (RRV) Vaccine works by stimulating the body's immune system to produce a specific response against the Ross River virus.
The Ross River Virus (RRV) Vaccine works by stimulating the body's immune system to produce a specific response against the Ross River virus. Used for Prevention of Ross River virus disease.
At a glance
| Generic name | Ross River Virus (RRV) Vaccine |
|---|---|
| Sponsor | Alachua Government Services, Inc. |
| Modality | Biologic |
| Therapeutic area | Virology |
| Phase | Phase 3 |
Mechanism of action
This vaccine contains a weakened or inactivated form of the virus, which triggers an immune response without causing the disease. The immune system then remembers how to fight the virus, providing long-term protection against future infections.
Approved indications
- Prevention of Ross River virus disease
Common side effects
- Pain, redness, or swelling at the injection site
Key clinical trials
- Ross River Virus (RRV) Vaccine Study (PHASE3)
- Safety and Immunogenicity Study of a Ross River Virus (RRV) Vaccine (PHASE1, PHASE2)
- Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801 (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ross River Virus (RRV) Vaccine CI brief — competitive landscape report
- Ross River Virus (RRV) Vaccine updates RSS · CI watch RSS
- Alachua Government Services, Inc. portfolio CI